Safety profile of D-penicillamine: a comprehensive pharmacovigilance analysis by FDA adverse event reporting system
CONCLUSIONS: Patients taking D-pen require close monitoring of renal function, blood counts, immunity, liver, cardiac function, and neurological function. D-pen suppresses immune system which maximizes the risk of infection.PMID:34259127 | DOI:10.1080/14740338.2021.1956460
Source: Expert Opinion on Drug Safety - Category: Drugs & Pharmacology Authors: Vijay Kumar Anand Prakash Singh Nicholas Wheeler Cristi L Galindo Jong-Joo Kim Source Type: research
More News: Arthritis | Brain | Copper | Databases & Libraries | Drugs & Pharmacology | Dystonia | Kidney Stones | Liver | Neurology | Pancytopenia | Rheumatoid Arthritis | Rheumatology | Urology & Nephrology | Wilson's Disease